ACTA FAC MED NAISS 2024;41(3):439-445 |
Case report
UDC:
616.8-008.9-07-08:615.065
DOI:
10.5937/afmnai41-47223
Running title:
Successful Treatment
of Drug-Induced Acute Intermittent Porphyria: A Case Report
Successful Treatment Response in a Patient with Severe Neurological
Manifestations of Drug-Induced Acute Intermittent Porphyria: A Case Report
Stefan Todorović1,
Gordana Đorđević1,2, Andrija Rančić3, Dejan Aleksić4
1University Clinical Center Niš, Clinic of Neurology,
Niš, Serbia
2University of Niš, Faculty of Medicine, Niš, Serbia
3University Clinical Center Niš, Clinic of
Gastroenterology and Hepatology, Niš, Serbia
4University of Kragujevac, Faculty of Medical
Sciences, Kragujevac, Serbia
SUMMARY
Introduction. Acute intermittent porphyria is a rare metabolic disorder of
the hem biosynthetic pathway that can cause severe neurological symptoms
involving the central, autonomic and peripheral nervous system. Diagnosis
may be delayed due to variable symptoms that can mimic other diseases.
Case report. A 23-year-old woman with abdominal pain, constipation,
progressive development of quadriparesis and bulbar palsy was admitted to
our intensive care unit two weeks after undergoing dental surgery.
Preventive antibiotic therapy (erythromycin) and bromocriptine (due to
cessation of breastfeeding) could represent precipitating factors for an
acute attack of the disease. The diagnosis was confirmed by a high level of
porphobilinogen and delta-aminolevulinic acid in urine. The patient was
treated conservatively with high carbohydrate intake and human hemin, with a
good treatment response. Two months after therapy, the patient was admitted
to the Department of Physical Medicine and Rehabilitation and started
physical therapy. There was a significant reduction of neurological
manifestations at the follow-up examination after three months.
Conclusion. Early diagnosis of acute intermittent porphyria is important for
the preventiing of serious consequences and applying of prompt therapy.
Further monitoring of patients is also important to avoid potential risk
factors that can trigger a porphyria attack.
Keywords:
diagnosis,
neurologic manifestation, acute intermittent porphyria, porphobilinogen,
delta-aminolevulinic acid, hemin
Corresponding author:
Stefan Todorović
e-mail:
todorovicstefan815@gmail.com